Acadia Healthcare appoints Christopher Hunter as new CEO, effective April 11, 2022

Acadia Healthcare Company, Inc.

Christopher Hunter named CEO and director; effective April 11, 2022; previously at Humana, TriZetto, BlueCross BlueShield.
CEO compensation: $1M base salary, 100% target bonus (max 200%), $1M RSUs (4-yr vest), $3.5M PSUs (target, 2022-2024).
Debbie Osteen to provide transition advisory services for $20,000/month; remains on Acadia Board.
Board expanded from 9 to 10 directors to accommodate Hunter's appointment.
Severance: 1.5x (salary+target) for non-CIC without cause/good reason; 2x for CIC; equity vesting provisions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher H. Hunter

Chief Executive Officer and Director

ACHC · Acadia Healthcare Company, Inc.

Effective: 2022-04-11
Filed: April 4, 2022, 7:59 PM ET

appointed Christopher H. Hunter as the Company’s new Chief Executive Officer and as a member of the Board, effective April 11, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher H. Hunter was appointed as Chief Executive Officer and Director at Acadia Healthcare Company, Inc..

Action: appointed
Role: Chief Executive Officer and Director

Exact text from the filing

appointed Christopher H. Hunter as the Company’s new Chief Executive Officer and as a member of the Board, effective April 11, 2022.

View on SEC.gov

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-22-000389

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.